Report Overview
Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc. The global Non-Animal Softgel Capsules market size is projected to grow from US$ 426 million in 2024 to US$ 577 million in 2030; it is expected to grow at a CAGR of 5.2% from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the ?Non-Animal Softgel Capsules Industry Forecast? looks at past sales and reviews total world Non-Animal Softgel Capsules sales in 2023, providing a comprehensive analysis by region and market sector of projected Non-Animal Softgel Capsules sales for 2024 through 2030. With Non-Animal Softgel Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Animal Softgel Capsules industry. This Insight Report provides a comprehensive analysis of the global Non-Animal Softgel Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Animal Softgel Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Animal Softgel Capsules market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Animal Softgel Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Animal Softgel Capsules. Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world. Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively. Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales. This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products. This report presents a comprehensive overview, market shares, and growth opportunities of Non-Animal Softgel Capsules market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Carrageenan Softgel Starch Softgel Gellan Gum Softgel Segmentation by Application: Health Supplements Pharmaceutical Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Catalent Procaps Laboratorios EuroCaps Baihe Aenova Captek Sirio Bahrain Pharma Robinson Pharma Aland Fuji Capsule Sunsho Pharmaceutical Erkang Key Questions Addressed in this Report What is the 10-year outlook for the global Non-Animal Softgel Capsules market? What factors are driving Non-Animal Softgel Capsules market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Non-Animal Softgel Capsules market opportunities vary by end market size? How does Non-Animal Softgel Capsules break out by Type, by Application?
Table Of Contents
Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2017-2029) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Non-Animal Softgel Capsules Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Non-Animal Softgel Capsules Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Non-Animal Softgel Capsules Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by region) 5 Global Non-Animal Softgel Capsules Market-Segmentation by Type 5.1 Type 1 5.2 Type 2 5.3 Type 3 6 Global Non-Animal Softgel Capsules Market-Segmentation by Application 6.1 Application 1 6.2 Application 2 6.3 Application 3 7 Global Non-Animal Softgel Capsules Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence A Company Profiles 8.1 Company 1 8.1.1 Company 1 Profile 8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023 8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis 8.1.4 Company 1 Business Overview/Recent Development/Acquisitions 8.2 Company 2 8.2.1 Company 2 Profile 8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023 8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis 8.2.4 Company 2 Business Overview/Recent Development/Acquisitions 8.3 Company 3 8.3.1 Company 3 Profile 8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023 8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis 8.3.4 Company 3 Business Overview/Recent Development/Acquisitions 8.4 Company 4 8.4.1 Company 4 Profile 8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023 8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis 8.4.4 Company 4 Business Overview/Recent Development/Acquisitions 8.5 Company 5 8.5.1 Company 5 Profile 8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023 8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis 8.5.4 Company 5 Business Overview/Recent Development/Acquisitions 8.6 Company 6 8.6.1 Company 6 Profile 8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023 8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis 8.6.4 Company 6 Business Overview/Recent Development/Acquisitions 8.7 Company 7 8.7.1 Company 7 Profile 8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023 8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis 8.7.4 Company 7 Business Overview/Recent Development/Acquisitions 8.8 Company 8 8.8.1 Company 8 Profile 8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023 8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis 8.8.4 Company 8 Business Overview/Recent Development/Acquisitions 8.9 Company 9 8.9.1 Company 9 Profile 8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023 8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis 8.9.4 Company 9 Business Overview/Recent Development/Acquisitions 8.10 Company 10 8.10.1 Company 10 Profile 8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023 8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis 8.10.4 Company 10 Business Overview/Recent Development/Acquisitions 8.11 Company 11 8.11.1 Company 11 Profile 8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023 8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis 8.11.4 Company 11 Business Overview/Recent Development/Acquisitions 8.12 Company 12 8.12.1 Company 12 Profile 8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023 8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis 8.12.4 Company 12 Business Overview/Recent Development/Acquisitions 8.13 Company 13 8.13.1 Company 13 Profile 8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023 8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis 8.13.4 Company 13 Business Overview/Recent Development/Acquisitions 8.14 Company 14 8.14.1 Company 14 Profile 8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023 8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis 8.14.4 Company 14 Business Overview/Recent Development/Acquisitions 8.15 Company 15 8.15.1 Company 15 Profile 8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023 8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis 8.15.4 Company 15 Business Overview/Recent Development/Acquisitions 9 Global Non-Animal Softgel Capsules Market-Segmentation by Geography 10 North America 10.1 North America Non-Animal Softgel Capsules Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 10.2 North America Non-Animal Softgel Capsules Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 10.3 North America Non-Animal Softgel Capsules Production Analysis from 2017-2023 10.4 North America Non-Animal Softgel Capsules Consumption Analysis from 2017-2023 10.5 North America Non-Animal Softgel Capsules Import and Export from 2017-2023 10.6 North America Non-Animal Softgel Capsules Value, Production and Market Share by Type (2017-2023) 10.7 North America Non-Animal Softgel Capsules Consumption, Value and Market Share by Application (2017-2023) 10.8 North America Non-Animal Softgel Capsules by Country (United States, Canada) 10.8.1 North America Non-Animal Softgel Capsules Sales by Country (2017-2023) 10.8.2 North America Non-Animal Softgel Capsules Consumption Value by Country (2017-2023) 10.9 North America Non-Animal Softgel Capsules Market PEST Analysis 11 Europe 11.1 Europe Non-Animal Softgel Capsules Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 11.2 Europe Non-Animal Softgel Capsules Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 11.3 Europe Non-Animal Softgel Capsules Production Analysis from 2017-2023 11.4 Europe Non-Animal Softgel Capsules Consumption Analysis from 2017-2023 11.5 Europe Non-Animal Softgel Capsules Import and Export from 2017-2023 11.6 Europe Non-Animal Softgel Capsules Value, Production and Market Share by Type (2017-2023) 11.7 Europe Non-Animal Softgel Capsules Consumption, Value and Market Share by Application (2017-2023) 11.8 Europe Non-Animal Softgel Capsules by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Non-Animal Softgel Capsules Sales by Country (2017-2023) 11.8.2 Europe Non-Animal Softgel Capsules Consumption Value by Country (2017-2023) 11.9 Europe Non-Animal Softgel Capsules Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Non-Animal Softgel Capsules Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 12.2 Asia-Pacific Non-Animal Softgel Capsules Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 12.3 Asia-Pacific Non-Animal Softgel Capsules Production Analysis from 2017-2023 12.4 Asia-Pacific Non-Animal Softgel Capsules Consumption Analysis from 2017-2023 12.5 Asia-Pacific Non-Animal Softgel Capsules Import and Export from 2017-2023 12.6 Asia-Pacific Non-Animal Softgel Capsules Value, Production and Market Share by Type (2017-2023) 12.7 Asia-Pacific Non-Animal Softgel Capsules Consumption, Value and Market Share by Application (2017-2023) 12.8 Asia-Pacific Non-Animal Softgel Capsules by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Non-Animal Softgel Capsules Sales by Country (2017-2023) 12.8.2 Asia-Pacific Non-Animal Softgel Capsules Consumption Value by Country (2017-2023) 12.9 Asia-Pacific Non-Animal Softgel Capsules Market PEST Analysis 13 Latin America 13.1 Latin America Non-Animal Softgel Capsules Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 13.2 Latin America Non-Animal Softgel Capsules Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 13.3 Latin America Non-Animal Softgel Capsules Production Analysis from 2017-2023 13.4 Latin America Non-Animal Softgel Capsules Consumption Analysis from 2017-2023 13.5 Latin America Non-Animal Softgel Capsules Import and Export from 2017-2023 13.6 Latin America Non-Animal Softgel Capsules Value, Production and Market Share by Type (2017-2023) 13.7 Latin America Non-Animal Softgel Capsules Consumption, Value and Market Share by Application (2017-2023) 13.8 Latin America Non-Animal Softgel Capsules by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Non-Animal Softgel Capsules Sales by Country (2017-2023) 13.8.2 Latin America Non-Animal Softgel Capsules Consumption Value by Country (2017-2023) 13.9 Latin America Non-Animal Softgel Capsules Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Non-Animal Softgel Capsules Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 14.2 Middle East & Africa Non-Animal Softgel Capsules Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 14.3 Middle East & Africa Non-Animal Softgel Capsules Production Analysis from 2017-2023 14.4 Middle East & Africa Non-Animal Softgel Capsules Consumption Analysis from 2017-2023 14.5 Middle East & Africa Non-Animal Softgel Capsules Import and Export from 2017-2023 14.6 Middle East & Africa Non-Animal Softgel Capsules Value, Production and Market Share by Type (2017-2023) 14.7 Middle East & Africa Non-Animal Softgel Capsules Consumption, Value and Market Share by Application (2017-2023) 14.8 Middle East & Africa Non-Animal Softgel Capsules by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Non-Animal Softgel Capsules Sales by Country (2017-2023) 14.8.2 Middle East & Africa Non-Animal Softgel Capsules Consumption Value by Country (2017-2023) 14.9 Middle East & Africa Non-Animal Softgel Capsules Market PEST Analysis 15 Future Forecast of the Global Non-Animal Softgel Capsules Market from 2023-2029 15.1 Future Forecast of the Global Non-Animal Softgel Capsules Market from 2023-2029 Segment by Region 15.2 Global Non-Animal Softgel Capsules Production and Growth Rate Forecast by Type (2023-2029) 15.3 Global Non-Animal Softgel Capsules Consumption and Growth Rate Forecast by Application (2023-2029) 16 Appendix 16.1 Methodology 16.2 Research Data Source